NCT04916392View on ClinicalTrials.gov

Observation Study of the Pharmacokinetics of Adductor Canal Block

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

March 31, 2022

Study Completion Date

April 4, 2023

Conditions
Toxicity, Drug
Interventions
DRUG

Liposomal bupivacaine

5ml of 1.33% liposomal bupivacaine with 5 ml of 0.9% normal saline will be given to treatment group.

Trial Locations (1)

Unknown

Queen Mary Hospital, Hong Kong

All Listed Sponsors
lead

The University of Hong Kong

OTHER

NCT04916392 - Observation Study of the Pharmacokinetics of Adductor Canal Block | Biotech Hunter | Biotech Hunter